Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer.
Prevezas
C
C
Matard
B
B
Pinquier
L
L
Reygagne
P
P
D000505:Alopecia / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000556:secondary; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects*; D043823:Taxoids / Q000009:adverse effects*
D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel